Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

/sup 3/H-Benzoyl-Ala-Gly-Pro: a new synthetic substrate of pulmonary endothelial angiotensin converting enzyme in vivo

Conference · · Fed. Proc., Fed. Am. Soc. Exp. Biol.; (United States)
OSTI ID:5450401
The authors have investigated the metabolism of /sup 3/H-Benzoyl-Ala-Gly-Pro (BAGP) by pulmonary angiotensin converting enzyme (ACE) in anesthetized rabbits utilizing indicator dilution techniques under first order reaction conditions. Arterial outflow curves of /sup 3/H and /sup 14/C-dextran were congruent, and indicator mean transit times were identical, indicating that both parent and product remained within the vascular spaces during a single transpulmonary passage. At normal pulmonary plasma flow (252 +/- 19) ml/min) single pass metabolism of /sup 3/H-BAGP averaged 59 +/- 3% (N = 5) and the Amax/Km ratio was 225 +/- 14 ml/min. When plasma flow was raised to 360 +/- 46 ml/min substrate metabolism was slightly but significantly reduced to 54 +/- 3%. Amax/Km, however, rose to 308 +/- 29 ml/min (p < 0.05) suggesting increased enzyme mass due to microvascular recruitment. The in vivo transpulmonary metabolism of /sup 3/H-BAGP is considerably less than that of the other commonly utilized substrate /sup 3/H-BPAP (80-90% conversion), agreeing with in vitro estimations of Kc/Km ratios for the two compounds (BAGP: 2.4 x 10/sup 7/, BPAP: 4.8 x 10/sup 7/ M/sup -1/ . sec/sup -1/). The use of /sup 3/H-BAGP as an AE substrate in vivo may prove advantageous when substantial alterations in pulmonary ACE activity are anticipated due to pathophysiological interventions.
Research Organization:
Medical College of Georgia, Augusta
OSTI ID:
5450401
Report Number(s):
CONF-8604222-
Conference Information:
Journal Name: Fed. Proc., Fed. Am. Soc. Exp. Biol.; (United States) Journal Volume: 45:3
Country of Publication:
United States
Language:
English